TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the γ-globin gene promoters.
Jiaqiong LinYuhua YeXuan ShangYanxia ZhangXiaofeng WeiXiangmin XuPublished in: British journal of haematology (2021)
Re-activation of fetal haemoglobin (HbF) has been proved to be an effective strategy for the treatment of β-haemoglobinopathies. In this study, we identified TEA domain transcription factor 4 (TEAD4) as a new potential regulator of HbF by integrating public data sets with quantitative polymerase chain reaction analysis in β-thalassaemia patients. Significant negative correlation was observed between the expression of TEAD4 and HbF levels in β-thalassaemia patients. Functional validations of TEAD4 inhibition in both β-thalassaemia CD34+ cells and HUDEP-2 cells indicated that depletion of TEAD4 led to a significant increase of HbF. Finally, we identified a binding motif of TEAD4 on γ-globin gene promoters; its disruption consistently led to de-repression of HbF. Taken together, these results demonstrate that TEAD4 could act as a transcriptional inhibitor of the γ-globin gene through direct binding on its promoter. Our findings demonstrate a novel role of TEAD4 on the regulation of HbF, which may benefit patients with β-haemoglobinopathies.
Keyphrases
- transcription factor
- end stage renal disease
- induced apoptosis
- newly diagnosed
- ejection fraction
- copy number
- dna binding
- genome wide
- chronic kidney disease
- gene expression
- genome wide identification
- cell cycle arrest
- poor prognosis
- cell death
- peritoneal dialysis
- binding protein
- high resolution
- risk assessment
- patient reported outcomes
- cell proliferation
- smoking cessation
- data analysis
- heat shock